Innsena Signs Impact Partnership With CancerX

By Amit Chowdhry • Updated February 15, 2024

Innsena – a health tech consultancy focused on improving care outcomes for underserved communities – announced a partnership with CancerX, a public-private partnership by The White House as a national accelerator to boost digital innovation in the fight against cancer as part of the reignited Cancer Moonshot. Innsena joins the initiative as its first Impact Supporter.

As an Impact Supporter, Innsena joins over 150 member organizations committed to accelerating digital innovations in the treatment and prevention of cancer for all patients, including our nation’s most vulnerable. And Innsena’s $100,000 contribution to CancerX will accelerate programs underway, including its program to improve equity and reduce financial toxicity in cancer care and research and to launch new initiatives more rapidly.

Innsena works with health technology organizations to positively impact the healthcare experience for individuals who are medically underserved, including disadvantaged and rural communities, and strengthen public health infrastructure in the US.

Patients without insurance and those on Medicaid are more likely to present with more advanced cancers. And cancer deaths are inequitably distributed and higher among non-white and rural populations. The disparities in the financial burden of fighting and surviving cancer, access to cancer care, and outcomes for the medically underserved have been well documented. Cancer is one of the most costly conditions in the US, and it is the second leading cause of death. And many underserved patients lack needed support and are left financially devastated by the burden of the disease.

As a CancerX Impact Partner, Innsena will collaborative with the public-private partnership to advise on health disparities, the needs of the underserved, access to care for rural and tribal communities, and other needs as its programs evolve.

CancerX was announced in February 2023 as part of The White House’s reignited national Cancer Moonshot initiative. And this represents a public-private partnership, co-hosted by Moffitt Cancer Center and the Digital Medicine Society (DiMe), along with the Office for the National Coordinator for Health Information Technology (ONC) and Office of the Assistant Secretary for Health (OASH).

KEY QUOTES:

“There are few conditions where the disparity in innovations benefiting underserved communities is more apparent than in the treatment and prevention of cancer. In CancerX, we found a community of partners delivering equitable solutions to hard problems, even when financial incentives do not otherwise exist.”

  • Kat McDavitt, president and founding partner of Innsena

“We decided that, if the incentives to innovate in cancer care for vulnerable populations don’t exist, then we would create them. Our financial commitment to CancerX is a step forward that we hope will start a broader movement among our industry peers.”

  • Leslie Kirk, CEO and managing partner of Innsena

“We’re grateful Innsena has chosen to join the CancerX community. This partnership will help us more rapidly pioneer and equitably deploy innovative solutions that can prevent and cure cancer and improve the lives of all people living with cancer.”

  • Jennifer Goldsack, CEO of the Digital Medicine Society (DiMe), co-host of CancerX